GuruTrack
LH

LH

LABCORP HOLDINGS INC

Data as of 2026 Q1 (03-31) · 13F snapshot

Summary
LABCORP HOLDINGS INC (LH) is held by 6 tracked hedge-fund managers, a combined reported value of ~$201.56M; the largest are Steven Cohen, Joel Greenblatt, Izzy Englander. This quarter: 1 new, 1 added, 3 trimmed. 20 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Gurus holding6
Congress trades20
Price$283.36vs quarter-end+6.20%
Sectors0
This quarter's moves
New1
Added1
Trimmed / sold3
Top holderSteven Cohen
Ken GriffinCALL—
Value $8.56M— of portfolio32,1002026 Q1
Izzy EnglanderPUT—
Value $4.62M— of portfolio17,6002025 Q2
Ken GriffinPUT—
Value $1.25M— of portfolio4,7002026 Q1
Izzy EnglanderCALL—
Value $498.8K— of portfolio1,9002025 Q2
Steven CohenCALL—
Value $266.8K— of portfolio1,0002026 Q1

Insider Trading

Officers · directors · Form 4

  • Kathryn W Kyle

    EVP, Chief Legal Officer

    Buy
    256Traded 2026-07-01Filed 2026-07-06

  • Kathryn W Kyle

    EVP, Chief Legal Officer

    Sell$20.7K
    73 @ $283.88Traded 2026-07-01Filed 2026-07-06

  • Kathryn W Kyle

    EVP, Chief Legal Officer

    Sell$26.3K
    92 @ $286.19Traded 2026-07-01Filed 2026-07-06

  • Bryan T Vaughn

    EVP and President, Diagnostics

    Sell$26.4K
    93 @ $283.88Traded 2026-07-01Filed 2026-07-06

  • Bryan T Vaughn

    EVP and President, Diagnostics

    Buy
    327Traded 2026-07-01Filed 2026-07-06

  • Bryan T Vaughn

    EVP and President, Diagnostics

    Sell$67.0K
    234 @ $286.19Traded 2026-07-01Filed 2026-07-06

  • Kathryn W Kyle

    EVP, Chief Legal Officer

    Sell$201.1K
    762 @ $263.89Traded 2026-06-08Filed 2026-06-10

  • Adam H Schechter

    President & CEO

    Sell$1.50M
    5,903 @ $254.50Traded 2026-05-11Filed 2026-05-13

  • Mark S Schroeder

    EVP, Pres Diagnostics & COO

    Sell$394.0K
    1,468 @ $268.38Traded 2026-03-26Filed 2026-03-30

  • Brian J Caveney

    EVP, Pres of ED, CMO & CSO

    Buy
    9,304 @ $0.00Traded 2026-03-26Filed 2026-03-30

  • Brian J Caveney

    EVP, Pres of ED, CMO & CSO

    Sell$1.08M
    4,042 @ $268.38Traded 2026-03-26Filed 2026-03-30

  • Brian J Caveney

    EVP, Pres of ED, CMO & CSO

    Buy
    1,986 @ $0.00Traded 2026-03-26Filed 2026-03-30

  • Brian J Caveney

    EVP, Pres of ED, CMO & CSO

    Sell$231.6K
    863 @ $268.38Traded 2026-03-26Filed 2026-03-30

  • Peter J Wilkinson

    SVP, Chief Accounting Officer

    Sell$436.1K
    1,633 @ $267.05Traded 2026-03-26Filed 2026-03-30

  • Peter J Wilkinson

    SVP, Chief Accounting Officer

    Buy
    2,388 @ $0.00Traded 2026-03-26Filed 2026-03-30

  • Peter J Wilkinson

    SVP, Chief Accounting Officer

    Sell$202.6K
    755 @ $268.38Traded 2026-03-26Filed 2026-03-30

  • Bryan T Vaughn

    EVP, Diagnostics

    Buy
    1,584 @ $0.00Traded 2026-03-26Filed 2026-03-30

  • Bryan T Vaughn

    EVP, Diagnostics

    Sell$121.0K
    451 @ $268.38Traded 2026-03-26Filed 2026-03-30

  • Sandra D Van Der Vaart

    EVP, Corporate Affairs

    Buy
    6,382 @ $0.00Traded 2026-03-26Filed 2026-03-30

  • Sandra D Van Der Vaart

    EVP, Corporate Affairs

    Sell$730.5K
    2,722 @ $268.38Traded 2026-03-26Filed 2026-03-30

  • Amy B. Summy

    EVP, Chief Marketing Officer

    Buy
    3,994 @ $0.00Traded 2026-03-26Filed 2026-03-30

  • Amy B. Summy

    EVP, Chief Marketing Officer

    Sell$492.7K
    1,836 @ $268.38Traded 2026-03-26Filed 2026-03-30

  • Akinbolade Oyegunwa

    EVP, CIO & CTO

    Buy
    1,340 @ $0.00Traded 2026-03-26Filed 2026-03-30

  • Akinbolade Oyegunwa

    EVP, CIO & CTO

    Sell$102.5K
    382 @ $268.38Traded 2026-03-26Filed 2026-03-30

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.